116903,0,Admission,O
116903,0,Date,O
116903,0,:,O
116903,0,[,O
116903,0,*,O
116903,0,*,O
116903,0,2138-3-20,O
116903,0,*,O
116903,0,*,O
116903,0,],O
116903,0,Discharge,O
116903,0,Date,O
116903,0,:,O
116903,0,[,O
116903,0,*,O
116903,0,*,O
116903,0,2138-4-7,O
116903,0,*,O
116903,0,*,O
116903,0,],O
116903,0,Date,O
116903,0,of,O
116903,0,Birth,O
116903,0,:,O
116903,0,[,O
116903,0,*,O
116903,0,*,O
116903,0,2091-2-17,O
116903,0,*,O
116903,0,*,O
116903,0,],O
116903,0,Sex,O
116903,0,:,O
116903,0,M,O
116903,0,Service,O
116903,0,:,O
116903,0,Medicine,O
116903,0,HISTORY,O
116903,0,OF,O
116903,0,PRESENT,O
116903,0,ILLNESS,O
116903,0,:,O
116903,0,The,O
116903,0,patient,O
116903,0,is,O
116903,0,a,O
116903,0,47-year-old,O
116903,0,gentleman,O
116903,0,with,O
116903,0,hepatitis,O
116903,0,C,O
116903,0,cirrhosis,O
116903,0,who,O
116903,0,is,O
116903,0,high,O
116903,0,up,O
116903,0,on,O
116903,0,the,O
116903,0,transplant,O
116903,0,list,O
116903,0,",",O
116903,0,who,O
116903,0,for,O
116903,0,the,O
116903,0,last,O
116903,0,five,O
116903,0,days,O
116903,0,prior,O
116903,0,to,O
116903,0,admission,O
116903,0,had,O
116903,0,been,O
116903,0,having,O
116903,0,decreased,O
116903,0,appetite,O
116903,0,",",O
116903,0,fatigue,O
116903,0,",",O
116903,0,nausea,O
116903,0,",",O
116903,0,and,O
116903,0,occasional,O
116903,0,vomiting,O
116903,0,.,O
116903,1,The,O
116903,1,patient,O
116903,1,'s,O
116903,1,diuretics,B-Drug
116903,1,were,O
116903,1,recently,O
116903,1,increased,O
116903,1,prior,O
116903,1,to,O
116903,1,admission,O
116903,1,to,O
116903,1,Lasix,B-Drug
116903,1,40,O
116903,1,and,O
116903,1,Aldactone,B-Drug
116903,1,100,O
116903,1,",",O
116903,1,but,O
116903,1,they,O
116903,1,were,O
116903,1,decreased,O
116903,1,to,O
116903,1,Lasix,B-Drug
116903,1,20,O
116903,1,and,O
116903,1,Aldactone,B-Drug
116903,1,50,O
116903,1,for,O
116903,1,elevated,B-ADE
116903,1,creatinines,I-ADE
116903,1,.,O
116903,1,The,O
116903,1,patient,O
116903,1,was,O
116903,1,found,O
116903,1,to,O
116903,1,have,O
116903,1,acute,O
116903,1,renal,O
116903,1,insufficiency,O
116903,1,by,O
116903,1,laboratories,O
116903,1,in,O
116903,1,clinic,O
116903,1,and,O
116903,1,was,O
116903,1,asked,O
116903,1,to,O
116903,1,come,O
116903,1,to,O
116903,1,the,O
116903,1,Emergency,O
116903,1,Department,O
116903,1,for,O
116903,1,further,O
116903,1,evaluation,O
116903,1,.,O
116903,1,In,O
116903,1,the,O
116903,1,Emergency,O
116903,1,Department,O
116903,1,",",O
116903,1,laboratories,O
116903,1,revealed,O
116903,1,a,O
116903,1,potassium,O
116903,1,of,O
116903,1,6.7,O
116903,1,and,O
116903,1,a,O
116903,1,creatinine,O
116903,1,of,O
116903,1,4.3,O
116903,1,.,O
116903,1,PAST,O
116903,1,MEDICAL,O
116903,1,HISTORY,O
116903,1,:,O
116903,1,(,O
116903,1,Significant,O
116903,1,for,O
116903,1,),O
116903,1,1,O
116903,1,.,O
116903,2,Hepatitis,O
116903,2,C,O
116903,2,cirrhosis,O
116903,2,;,O
116903,2,requiring,O
116903,2,liver,O
116903,2,transplantation,O
116903,2,",",O
116903,2,the,O
116903,2,patient,O
116903,2,is,O
116903,2,currently,O
116903,2,on,O
116903,2,liver,O
116903,2,transplant,O
116903,2,list,O
116903,2,.,O
116903,2,2,O
116903,2,.,O
116903,2,Hypertension,O
116903,2,.,O
116903,2,3,O
116903,2,.,O
116903,2,History,O
116903,2,of,O
116903,2,nephrolithiasis,O
116903,2,.,O
116903,2,MEDICATIONS,O
116903,2,ON,O
116903,2,ADMISSION,O
116903,2,:,O
116903,2,1,O
116903,2,.,O
116903,2,Aldactone,B-Drug
116903,2,50,O
116903,2,mg.,O
116903,2,2,O
116903,2,.,O
116903,2,Lasix,B-Drug
116903,2,20,O
116903,2,mg.,O
116903,2,3,O
116903,2,.,O
116903,2,Flagyl,B-Drug
116903,2,250,O
116903,2,mg,O
116903,2,three,O
116903,2,times,O
116903,2,per,O
116903,2,day,O
116903,2,.,O
116903,2,4,O
116903,2,.,O
116903,2,Quinine,B-Drug
116903,2,325,O
116903,2,mg,O
116903,2,once,O
116903,2,per,O
116903,2,day,O
116903,2,.,O
116903,2,5,O
116903,2,.,O
116903,2,Protonix,B-Drug
116903,2,40,O
116903,2,mg,O
116903,2,once,O
116903,2,per,O
116903,2,day,O
116903,2,.,O
116903,2,6,O
116903,2,.,O
116903,2,Magnesium,B-Drug
116903,2,oxide,I-Drug
116903,2,800,O
116903,2,mg,O
116903,2,twice,O
116903,2,per,O
116903,2,day,O
116903,2,.,O
116903,3,7,O
116903,3,.,O
116903,3,Oxycodone,B-Drug
116903,3,2,O
116903,3,mg,O
116903,3,to,O
116903,3,4,O
116903,3,mg,O
116903,3,as,O
116903,3,needed,O
116903,3,.,O
116903,3,ALLERGIES,O
116903,3,:,O
116903,3,The,O
116903,3,patient,O
116903,3,has,O
116903,3,allergies,B-ADE
116903,3,to,O
116903,3,CODEINE,B-Drug
116903,3,(,O
116903,3,which,O
116903,3,causes,O
116903,3,gastrointestinal,B-ADE
116903,3,upset,I-ADE
116903,3,),O
116903,3,.,O
116903,3,SOCIAL,O
116903,3,HISTORY,O
116903,3,:,O
116903,3,He,O
116903,3,lives,O
116903,3,at,O
116903,3,home,O
116903,3,with,O
116903,3,his,O
116903,3,wife,O
116903,3,.,O
116903,3,[,O
116903,3,*,O
116903,3,*,O
116903,3,Name,O
116903,3,(,O
116903,3,NI,O
116903,3,),O
116903,3,*,O
116903,3,*,O
116903,3,],O
116903,3,is,O
116903,3,a,O
116903,3,past,O
116903,3,alcohol,O
116903,3,abuser,O
116903,3,who,O
116903,3,now,O
116903,3,works,O
116903,3,as,O
116903,3,a,O
116903,3,substance,O
116903,3,abuse,O
116903,3,counselor,O
116903,3,.,O
116903,3,FAMILY,O
116903,3,HISTORY,O
116903,3,:,O
116903,3,Significant,O
116903,3,for,O
116903,3,father,O
116903,3,who,O
116903,3,died,O
116903,3,of,O
116903,3,a,O
116903,3,myocardial,O
116903,3,infarction,O
116903,3,at,O
116903,3,the,O
116903,3,age,O
116903,3,of,O
116903,3,38,O
116903,3,.,O
116903,4,PHYSICAL,O
116903,4,EXAMINATION,O
116903,4,ON,O
116903,4,PRESENTATION,O
116903,4,:,O
116903,4,On,O
116903,4,admission,O
116903,4,",",O
116903,4,the,O
116903,4,patient,O
116903,4,was,O
116903,4,afebrile,O
116903,4,.,O
116903,4,He,O
116903,4,had,O
116903,4,a,O
116903,4,blood,O
116903,4,pressure,O
116903,4,of,O
116903,4,130/58,O
116903,4,",",O
116903,4,a,O
116903,4,pulse,O
116903,4,of,O
116903,4,70,O
116903,4,",",O
116903,4,a,O
116903,4,respiratory,O
116903,4,rate,O
116903,4,of,O
116903,4,20,O
116903,4,",",O
116903,4,and,O
116903,4,was,O
116903,4,saturating,O
116903,4,97,O
116903,4,%,O
116903,4,on,O
116903,4,room,O
116903,4,air,O
116903,4,.,O
116903,4,He,O
116903,4,was,O
116903,4,in,O
116903,4,no,O
116903,4,apparent,O
116903,4,distress,O
116903,4,.,O
116903,4,He,O
116903,4,was,O
116903,4,anicteric,O
116903,4,.,O
116903,4,His,O
116903,4,pupils,O
116903,4,were,O
116903,4,reactive,O
116903,4,.,O
116903,4,His,O
116903,4,extraocular,O
116903,4,movements,O
116903,4,were,O
116903,4,intact,O
116903,4,.,O
116903,4,The,O
116903,4,lungs,O
116903,4,were,O
116903,4,clear,O
116903,4,bilaterally,O
116903,4,.,O
116903,4,His,O
116903,4,cardiac,O
116903,4,examination,O
116903,4,showed,O
116903,4,normal,O
116903,4,first,O
116903,4,heart,O
116903,4,sounds,O
116903,4,and,O
116903,4,second,O
116903,4,heart,O
116903,4,sounds,O
116903,4,with,O
116903,4,a,O
116903,4,2/6,O
116903,4,systolic,O
116903,4,murmur,O
116903,4,at,O
116903,4,the,O
116903,4,right,O
116903,4,upper,O
116903,4,sternal,O
116903,4,border,O
116903,4,.,O
116903,5,His,O
116903,5,abdomen,O
116903,5,was,O
116903,5,soft,O
116903,5,",",O
116903,5,mildly,O
116903,5,distended,O
116903,5,",",O
116903,5,and,O
116903,5,nontender,O
116903,5,.,O
116903,5,He,O
116903,5,had,O
116903,5,no,O
116903,5,peripheral,O
116903,5,edema,O
116903,5,.,O
116903,5,PERTINENT,O
116903,5,LABORATORY,O
116903,5,VALUES,O
116903,5,ON,O
116903,5,PRESENTATION,O
116903,5,:,O
116903,5,He,O
116903,5,had,O
116903,5,a,O
116903,5,white,O
116903,5,blood,O
116903,5,cell,O
116903,5,count,O
116903,5,of,O
116903,5,5.6,O
116903,5,",",O
116903,5,his,O
116903,5,hematocrit,O
116903,5,was,O
116903,5,28.4,O
116903,5,",",O
116903,5,and,O
116903,5,he,O
116903,5,had,O
116903,5,platelets,O
116903,5,of,O
116903,5,101,O
116903,5,.,O
116903,5,He,O
116903,5,had,O
116903,5,an,O
116903,5,INR,O
116903,5,of,O
116903,5,1.9,O
116903,5,.,O
116903,5,Chemistry-7,O
116903,5,showed,O
116903,5,an,O
116903,5,initial,O
116903,5,creatinine,O
116903,5,of,O
116903,5,4.2,O
116903,5,with,O
116903,5,a,O
116903,5,potassium,O
116903,5,of,O
116903,5,6.7,O
116903,5,.,O
116903,5,After,O
116903,5,gentle,O
116903,5,fluids,O
116903,5,and,O
116903,5,treatment,O
116903,5,for,O
116903,5,his,O
116903,5,potassium,O
116903,5,",",O
116903,5,he,O
116903,5,had,O
116903,5,a,O
116903,5,repeat,O
116903,5,potassium,O
116903,5,of,O
116903,5,5.7,O
116903,5,and,O
116903,5,a,O
116903,5,creatinine,O
116903,5,of,O
116903,5,3.9,O
116903,5,.,O
116903,6,He,O
116903,6,had,O
116903,6,an,O
116903,6,alanine-aminotransferase,O
116903,6,of,O
116903,6,57,O
116903,6,",",O
116903,6,his,O
116903,6,aspartate,O
116903,6,aminotransferase,O
116903,6,was,O
116903,6,166,O
116903,6,",",O
116903,6,his,O
116903,6,alkaline,O
116903,6,phosphatase,O
116903,6,was,O
116903,6,101,O
116903,6,",",O
116903,6,and,O
116903,6,his,O
116903,6,total,O
116903,6,bilirubin,O
116903,6,was,O
116903,6,3.7,O
116903,6,.,O
116903,6,PERTINENT,O
116903,6,RADIOLOGY/IMAGING,O
116903,6,:,O
116903,6,An,O
116903,6,electrocardiogram,O
116903,6,showed,O
116903,6,a,O
116903,6,normal,O
116903,6,sinus,O
116903,6,rhythm,O
116903,6,.,O
116903,6,There,O
116903,6,were,O
116903,6,no,O
116903,6,peaked,O
116903,6,T,O
116903,6,waves,O
116903,6,.,O
116903,6,Otherwise,O
116903,6,",",O
116903,6,his,O
116903,6,electrocardiogram,O
116903,6,was,O
116903,6,normal,O
116903,6,.,O
116903,6,BRIEF,O
116903,6,SUMMARY,O
116903,6,OF,O
116903,6,HOSPITAL,O
116903,6,COURSE,O
116903,6,:,O
116903,6,The,O
116903,6,patient,O
116903,6,was,O
116903,6,admitted,O
116903,6,for,O
116903,6,his,O
116903,6,acute,B-ADE
116903,6,renal,I-ADE
116903,6,insufficiency,I-ADE
116903,6,.,O
116903,6,His,O
116903,6,Lasix,B-Drug
116903,6,and,O
116903,6,his,O
116903,6,Aldactone,B-Drug
116903,6,were,O
116903,6,held,O
116903,6,.,O
116903,6,His,O
116903,6,hyperkalemia,B-Reason
116903,6,responded,O
116903,6,well,O
116903,6,to,O
116903,6,his,O
116903,6,Kayexalate,B-Drug
116903,6,therapy,O
116903,6,.,O
116903,7,The,O
116903,7,patient,O
116903,7,was,O
116903,7,noted,O
116903,7,to,O
116903,7,have,O
116903,7,some,O
116903,7,mild,O
116903,7,periorbital,O
116903,7,erythema,O
116903,7,and,O
116903,7,edema,O
116903,7,on,O
116903,7,the,O
116903,7,right,O
116903,7,side,O
116903,7,of,O
116903,7,his,O
116903,7,face,O
116903,7,.,O
116903,7,He,O
116903,7,was,O
116903,7,initially,O
116903,7,started,O
116903,7,on,O
116903,7,doxycycline,B-Drug
116903,7,for,O
116903,7,this,O
116903,7,presumed,B-Reason
116903,7,preseptal,I-Reason
116903,7,cellulitis,I-Reason
116903,7,.,O
116903,7,The,O
116903,7,patient,O
116903,7,'s,O
116903,7,creatinine,O
116903,7,did,O
116903,7,initially,O
116903,7,improve,O
116903,7,;,O
116903,7,however,O
116903,7,",",O
116903,7,it,O
116903,7,started,O
116903,7,to,O
116903,7,increase,O
116903,7,again,O
116903,7,slowly,O
116903,7,during,O
116903,7,the,O
116903,7,course,O
116903,7,of,O
116903,7,his,O
116903,7,hospital,O
116903,7,stay,O
116903,7,.,O
116903,7,Initially,O
116903,7,",",O
116903,7,it,O
116903,7,was,O
116903,7,felt,O
116903,7,that,O
116903,7,the,O
116903,7,patient's,O
116903,7,initial,O
116903,7,presentation,O
116903,7,of,O
116903,7,acute,B-ADE
116903,7,renal,I-ADE
116903,7,insufficiency,I-ADE
116903,7,was,O
116903,7,secondary,O
116903,7,to,O
116903,7,aggressive,O
116903,7,diuresis,B-Drug
116903,7,;,O
116903,7,however,O
116903,7,",",O
116903,7,in,O
116903,7,the,O
116903,7,setting,O
116903,7,of,O
116903,7,his,O
116903,7,diuretics,O
116903,7,being,O
116903,7,held,O
116903,7,and,O
116903,7,his,O
116903,7,continued,O
116903,7,increase,O
116903,7,in,O
116903,7,his,O
116903,7,creatinine,O
116903,7,",",O
116903,7,it,O
116903,7,was,O
116903,7,possible,O
116903,7,that,O
116903,7,he,O
116903,7,could,O
116903,8,have,O
116903,8,the,O
116903,8,initial,O
116903,8,stages,O
116903,8,of,O
116903,8,hepatorenal,O
116903,8,syndrome,O
116903,8,.,O
116903,8,The,O
116903,8,patient,O
116903,8,has,O
116903,8,had,O
116903,8,elevated,O
116903,8,creatinines,O
116903,8,on,O
116903,8,previous,O
116903,8,hospitalizations,O
116903,8,",",O
116903,8,presumed,O
116903,8,to,O
116903,8,be,O
116903,8,related,O
116903,8,to,O
116903,8,hepatorenal,B-Reason
116903,8,syndrome,I-Reason
116903,8,.,O
116903,8,The,O
116903,8,patient,O
116903,8,was,O
116903,8,started,O
116903,8,on,O
116903,8,octreotide,B-Drug
116903,8,and,O
116903,8,midodrine,B-Drug
116903,8,.,O
116903,8,Also,O
116903,8,in,O
116903,8,the,O
116903,8,setting,O
116903,8,of,O
116903,8,his,O
116903,8,acute,B-ADE
116903,8,renal,I-ADE
116903,8,insufficiency,I-ADE
116903,8,",",O
116903,8,his,O
116903,8,tetracycline,B-Drug
116903,8,was,O
116903,8,held,O
116903,8,as,O
116903,8,it,O
116903,8,was,O
116903,8,possible,O
116903,8,that,O
116903,8,this,O
116903,8,could,O
116903,8,be,O
116903,8,a,O
116903,8,contributing,O
116903,8,factor,O
116903,8,.,O
116903,8,An,O
116903,8,Ophthalmology,O
116903,8,consultation,O
116903,8,was,O
116903,8,obtained,O
116903,8,which,O
116903,8,showed,O
116903,8,just,O
116903,8,some,O
116903,8,very,O
116903,8,mild,B-Reason
116903,8,preseptal,I-Reason
116903,8,cellulitis,I-Reason
116903,8,with,O
116903,8,no,O
116903,8,orbital,O
116903,8,signs,O
116903,8,or,O
116903,8,symptoms,O
116903,8,suggestive,O
116903,8,of,O
116903,8,an,O
116903,8,orbital,B-Reason
116903,8,cellulitis,I-Reason
116903,8,.,O
116903,9,The,O
116903,9,patient,O
116903,9,'s,O
116903,9,doxycycline,B-Drug
116903,9,was,O
116903,9,discontinued,O
116903,9,in,O
116903,9,favor,O
116903,9,of,O
116903,9,Keflex,B-Drug
116903,9,.,O
116903,9,The,O
116903,9,patient,O
116903,9,did,O
116903,9,have,O
116903,9,urine,O
116903,9,eosinophils,O
116903,9,and,O
116903,9,sediment,O
116903,9,checked,O
116903,9,.,O
116903,9,He,O
116903,9,had,O
116903,9,bland,O
116903,9,sediment,O
116903,9,which,O
116903,9,was,O
116903,9,not,O
116903,9,consistent,O
116903,9,with,O
116903,9,an,O
116903,9,acute,O
116903,9,tubular,O
116903,9,necrosis,O
116903,9,type,O
116903,9,picture,O
116903,9,.,O
116903,9,The,O
116903,9,patient,O
116903,9,was,O
116903,9,also,O
116903,9,transfused,O
116903,9,with,O
116903,9,2,O
116903,9,units,O
116903,9,of,O
116903,9,packed,B-Drug
116903,9,red,I-Drug
116903,9,blood,I-Drug
116903,9,cells,I-Drug
116903,9,for,O
116903,9,a,O
116903,9,low,B-Reason
116903,9,hematocrit,I-Reason
116903,9,early,O
116903,9,on,O
116903,9,during,O
116903,9,the,O
116903,9,course,O
116903,9,of,O
116903,9,his,O
116903,9,hospital,O
116903,9,stay,O
116903,9,.,O
116903,9,The,O
116903,9,patient,O
116903,9,did,O
116903,9,not,O
116903,9,have,O
116903,9,any,O
116903,9,upper,O
116903,9,endoscopy,O
116903,9,as,O
116903,9,his,O
116903,9,anemia,O
116903,9,was,O
116903,9,not,O
116903,9,suspected,O
116903,9,to,O
116903,9,be,O
116903,9,secondary,O
116903,9,to,O
116903,9,esophageal,O
116903,9,varices,O
116903,9,.,O
116903,10,The,O
116903,10,patient,O
116903,10,'s,O
116903,10,creatinine,B-ADE
116903,10,continued,I-ADE
116903,10,to,I-ADE
116903,10,rise,I-ADE
116903,10,in,O
116903,10,the,O
116903,10,setting,O
116903,10,of,O
116903,10,his,O
116903,10,octreotide,B-Drug
116903,10,and,O
116903,10,midodrine,B-Drug
116903,10,therapy,O
116903,10,.,O
116903,10,Because,O
116903,10,of,O
116903,10,this,O
116903,10,",",O
116903,10,albumin,B-Drug
116903,10,25,O
116903,10,grams,O
116903,10,intravenously,O
116903,10,once,O
116903,10,per,O
116903,10,day,O
116903,10,was,O
116903,10,also,O
116903,10,started,O
116903,10,.,O
116903,10,On,O
116903,10,[,O
116903,10,*,O
116903,10,*,O
116903,10,2138-3-29,O
116903,10,*,O
116903,10,*,O
116903,10,],O
116903,10,",",O
116903,10,the,O
116903,10,patient,O
116903,10,became,O
116903,10,encephalopathic,O
116903,10,.,O
116903,10,Blood,O
116903,10,cultures,O
116903,10,and,O
116903,10,urine,O
116903,10,cultures,O
116903,10,were,O
116903,10,sent,O
116903,10,",",O
116903,10,and,O
116903,10,he,O
116903,10,did,O
116903,10,have,O
116903,10,an,O
116903,10,episode,O
116903,10,of,O
116903,10,occult-blood,O
116903,10,positive,O
116903,10,stools,O
116903,10,.,O
116903,10,In,O
116903,10,the,O
116903,10,setting,O
116903,10,of,O
116903,10,his,O
116903,10,encephalopathy,B-Reason
116903,10,",",O
116903,10,his,O
116903,10,renal,O
116903,10,function,O
116903,10,did,O
116903,10,improve,O
116903,10,;,O
116903,10,however,O
116903,10,",",O
116903,10,he,O
116903,10,was,O
116903,10,transferred,O
116903,10,to,O
116903,10,the,O
116903,10,Unit,O
116903,10,for,O
116903,10,further,O
116903,10,observation,O
116903,10,.,O
116903,11,A,O
116903,11,nasogastric,O
116903,11,lavage,B-Drug
116903,11,was,O
116903,11,done,O
116903,11,in,O
116903,11,the,O
116903,11,setting,O
116903,11,of,O
116903,11,his,O
116903,11,occult-blood,B-Reason
116903,11,positive,I-Reason
116903,11,stool,I-Reason
116903,11,.,O
116903,11,The,O
116903,11,nasogastric,O
116903,11,lavage,B-Drug
116903,11,was,O
116903,11,negative,O
116903,11,for,O
116903,11,blood,O
116903,11,.,O
116903,11,He,O
116903,11,did,O
116903,11,have,O
116903,11,a,O
116903,11,STAT,O
116903,11,head,O
116903,11,computed,O
116903,11,tomography,O
116903,11,which,O
116903,11,was,O
116903,11,negative,O
116903,11,for,O
116903,11,bleed,O
116903,11,.,O
116903,11,All,O
116903,11,sedatives,B-Drug
116903,11,were,O
116903,11,discontinued,O
116903,11,",",O
116903,11,and,O
116903,11,he,O
116903,11,was,O
116903,11,started,O
116903,11,on,O
116903,11,lactulose,B-Drug
116903,11,therapy,O
116903,11,.,O
116903,11,A,O
116903,11,chest,O
116903,11,x-ray,O
116903,11,there,O
116903,11,was,O
116903,11,negative,O
116903,11,for,O
116903,11,a,O
116903,11,pneumonia,O
116903,11,.,O
116903,11,The,O
116903,11,patient,O
116903,11,did,O
116903,11,have,O
116903,11,serial,O
116903,11,blood,O
116903,11,cultures,O
116903,11,done,O
116903,11,.,O
116903,11,He,O
116903,11,did,O
116903,11,have,O
116903,11,a,O
116903,11,total,O
116903,11,of,O
116903,11,[,O
116903,11,*,O
116903,11,*,O
116903,11,6-26,O
116903,11,*,O
116903,11,*,O
116903,11,],O
116903,11,blood,O
116903,11,cultures,O
116903,11,positive,O
116903,11,for,O
116903,11,methicillin-resistant,O
116903,11,coagulase-negative,O
116903,11,Staphylococcus,O
116903,11,.,O
116903,12,His,O
116903,12,mental,B-Reason
116903,12,status,I-Reason
116903,12,did,O
116903,12,improve,O
116903,12,on,O
116903,12,lactulose,B-Drug
116903,12,therapy,O
116903,12,.,O
116903,12,The,O
116903,12,origin,O
116903,12,of,O
116903,12,his,O
116903,12,staphylococcal,B-Reason
116903,12,bacteremia,I-Reason
116903,12,was,O
116903,12,still,O
116903,12,uncertain,O
116903,12,.,O
116903,12,In,O
116903,12,this,O
116903,12,setting,O
116903,12,",",O
116903,12,he,O
116903,12,did,O
116903,12,have,O
116903,12,a,O
116903,12,diagnostic,O
116903,12,paracentesis,O
116903,12,done,O
116903,12,which,O
116903,12,was,O
116903,12,negative,O
116903,12,for,O
116903,12,spontaneous,O
116903,12,bacterial,O
116903,12,peritonitis,O
116903,12,.,O
116903,12,The,O
116903,12,patient,O
116903,12,was,O
116903,12,started,O
116903,12,on,O
116903,12,vancomycin,B-Drug
116903,12,for,O
116903,12,his,O
116903,12,high-grade,B-Reason
116903,12,bacteremia,I-Reason
116903,12,.,O
116903,12,He,O
116903,12,did,O
116903,12,have,O
116903,12,a,O
116903,12,transesophageal,O
116903,12,echocardiogram,O
116903,12,done,O
116903,12,which,O
116903,12,was,O
116903,12,negative,O
116903,12,for,O
116903,12,endocarditis,O
116903,12,.,O
116903,12,Per,O
116903,12,the,O
116903,12,Infectious,O
116903,12,Disease,O
116903,12,staff,O
116903,12,",",O
116903,12,it,O
116903,12,was,O
116903,12,recommended,O
116903,12,that,O
116903,12,he,O
116903,12,be,O
116903,12,treated,O
116903,12,with,O
116903,12,four,O
116903,12,to,O
116903,12,six,O
116903,12,weeks,O
116903,12,of,O
116903,12,vancomycin,B-Drug
116903,12,from,O
116903,12,the,O
116903,12,date,O
116903,12,of,O
116903,12,his,O
116903,12,last,O
116903,12,positive,O
116903,12,blood,O
116903,12,cultures,O
116903,12,which,O
116903,12,were,O
116903,12,[,O
116903,12,*,O
116903,12,*,O
116903,12,2138-3-30,O
116903,12,*,O
116903,12,*,O
116903,12,],O
116903,13,.,O
116903,13,The,O
116903,13,patient,O
116903,13,was,O
116903,13,transferred,O
116903,13,back,O
116903,13,to,O
116903,13,the,O
116903,13,floor,O
116903,13,with,O
116903,13,an,O
116903,13,improved,O
116903,13,mental,O
116903,13,status,O
116903,13,and,O
116903,13,improved,O
116903,13,renal,O
116903,13,function,O
116903,13,.,O
116903,13,He,O
116903,13,did,O
116903,13,well,O
116903,13,on,O
116903,13,the,O
116903,13,floor,O
116903,13,.,O
116903,13,His,O
116903,13,hematocrit,O
116903,13,remained,O
116903,13,stable,O
116903,13,.,O
116903,13,He,O
116903,13,remained,O
116903,13,afebrile,O
116903,13,on,O
116903,13,vancomycin,B-Drug
116903,13,.,O
116903,13,The,O
116903,13,patient,O
116903,13,also,O
116903,13,completed,O
116903,13,a,O
116903,13,course,O
116903,13,of,O
116903,13,levofloxacin,B-Drug
116903,13,for,O
116903,13,his,O
116903,13,preseptal,B-Reason
116903,13,cellulitis,I-Reason
116903,13,.,O
116903,13,For,O
116903,13,his,O
116903,13,preseptal,B-Reason
116903,13,cellulitis,I-Reason
116903,13,",",O
116903,13,he,O
116903,13,received,O
116903,13,a,O
116903,13,total,O
116903,13,of,O
116903,13,10,O
116903,13,days,O
116903,13,of,O
116903,13,antibiotics,B-Drug
116903,13,which,O
116903,13,included,O
116903,13,doxycycline,B-Drug
116903,13,",",O
116903,13,Keflex,B-Drug
116903,13,",",O
116903,13,and,O
116903,13,levofloxacin,B-Drug
116903,13,.,O
116903,13,The,O
116903,13,patient,O
116903,13,did,O
116903,13,have,O
116903,13,good,O
116903,13,nutritional,O
116903,13,intake,O
116903,13,while,O
116903,13,on,O
116903,13,the,O
116903,13,floor,O
116903,13,.,O
116903,14,His,O
116903,14,creatinine,O
116903,14,remained,O
116903,14,in,O
116903,14,the,O
116903,14,1.6,O
116903,14,to,O
116903,14,1.9,O
116903,14,range,O
116903,14,on,O
116903,14,the,O
116903,14,floor,O
116903,14,and,O
116903,14,stable,O
116903,14,.,O
116903,14,His,O
116903,14,baseline,O
116903,14,creatinine,O
116903,14,is,O
116903,14,around,O
116903,14,1,O
116903,14,.,O
116903,14,He,O
116903,14,was,O
116903,14,not,O
116903,14,started,O
116903,14,on,O
116903,14,diuretics,B-Drug
116903,14,at,O
116903,14,discharge,O
116903,14,.,O
116903,14,A,O
116903,14,peripherally,O
116903,14,inserted,O
116903,14,central,O
116903,14,catheter,O
116903,14,line,O
116903,14,was,O
116903,14,placed,O
116903,14,for,O
116903,14,administration,O
116903,14,of,O
116903,14,intravenous,O
116903,14,vancomycin,B-Drug
116903,14,for,O
116903,14,his,O
116903,14,high-grade,O
116903,14,methicillin-resistant,O
116903,14,Staphylococcus,O
116903,14,epidermitis,O
116903,14,bacteremia,O
116903,14,.,O
116903,14,The,O
116903,14,patient,O
116903,14,was,O
116903,14,seen,O
116903,14,by,O
116903,14,Physical,O
116903,14,Therapy,O
116903,14,and,O
116903,14,was,O
116903,14,discharged,O
116903,14,from,O
116903,14,their,O
116903,14,service,O
116903,14,as,O
116903,14,he,O
116903,14,had,O
116903,14,no,O
116903,14,acute,O
116903,14,physical,O
116903,14,therapy,O
116903,14,needs,O
116903,14,.,O
116903,14,The,O
116903,14,patient,O
116903,14,did,O
116903,14,have,O
116903,14,a,O
116903,14,candidal,B-Reason
116903,14,infection,I-Reason
116903,14,of,I-Reason
116903,14,his,I-Reason
116903,14,groin,I-Reason
116903,14,area,I-Reason
116903,14,which,O
116903,14,was,O
116903,14,treated,O
116903,14,with,O
116903,14,topical,O
116903,14,anti-fungal,B-Drug
116903,14,medications,I-Drug
116903,14,",",O
116903,14,to,O
116903,14,which,O
116903,14,he,O
116903,14,responded,O
116903,14,well,O
116903,14,to,O
116903,14,.,O
116903,15,Toward,O
116903,15,the,O
116903,15,end,O
116903,15,of,O
116903,15,his,O
116903,15,hospital,O
116903,15,stay,O
116903,15,",",O
116903,15,the,O
116903,15,patient,O
116903,15,did,O
116903,15,have,O
116903,15,increased,O
116903,15,diarrhea,O
116903,15,.,O
116903,15,His,O
116903,15,lactulose,B-Drug
116903,15,was,O
116903,15,held,O
116903,15,which,O
116903,15,improved,O
116903,15,his,O
116903,15,diarrhea,B-ADE
116903,15,somewhat,O
116903,15,;,O
116903,15,however,O
116903,15,",",O
116903,15,he,O
116903,15,did,O
116903,15,complain,O
116903,15,of,O
116903,15,increased,O
116903,15,diarrhea,O
116903,15,.,O
116903,15,He,O
116903,15,did,O
116903,15,have,O
116903,15,Clostridium,O
116903,15,difficile,O
116903,15,toxins,O
116903,15,times,O
116903,15,three,O
116903,15,days,O
116903,15,which,O
116903,15,were,O
116903,15,sent,O
116903,15,.,O
116903,15,These,O
116903,15,were,O
116903,15,negative,O
116903,15,for,O
116903,15,Clostridium,O
116903,15,difficile,O
116903,15,.,O
116903,15,The,O
116903,15,patient,O
116903,15,was,O
116903,15,discharged,O
116903,15,on,O
116903,15,no,O
116903,15,diuretics,B-Drug
116903,15,;,O
116903,15,however,O
116903,15,",",O
116903,15,the,O
116903,15,possibility,O
116903,15,of,O
116903,15,restarting,O
116903,15,Aldactone,B-Drug
116903,15,50,O
116903,15,mg,O
116903,15,will,O
116903,15,be,O
116903,15,considered,O
116903,15,as,O
116903,15,an,O
116903,15,outpatient,O
116903,15,.,O
116903,16,He,O
116903,16,will,O
116903,16,be,O
116903,16,discharged,O
116903,16,with,O
116903,16,a,O
116903,16,total,O
116903,16,course,O
116903,16,of,O
116903,16,four,O
116903,16,to,O
116903,16,six,O
116903,16,weeks,O
116903,16,of,O
116903,16,vancomycin,B-Drug
116903,16,.,O
116903,16,The,O
116903,16,start,O
116903,16,date,O
116903,16,on,O
116903,16,his,O
116903,16,vancomycin,B-Drug
116903,16,was,O
116903,16,[,O
116903,16,*,O
116903,16,*,O
116903,16,2138-3-30,O
116903,16,*,O
116903,16,*,O
116903,16,],O
116903,16,.,O
116903,16,CONDITION,O
116903,16,AT,O
116903,16,DISCHARGE,O
116903,16,:,O
116903,16,Fair,O
116903,16,.,O
116903,16,DISCHARGE,O
116903,16,STATUS,O
116903,16,:,O
116903,16,To,O
116903,16,home,O
116903,16,.,O
116903,16,DISCHARGE,O
116903,16,DIAGNOSES,O
116903,16,:,O
116903,16,1,O
116903,16,.,O
116903,16,Hepatitis,O
116903,16,C,O
116903,16,cirrhosis,O
116903,16,;,O
116903,16,awaiting,O
116903,16,liver,O
116903,16,transplantation,O
116903,16,.,O
116903,16,2,O
116903,16,.,O
116903,16,Acute,O
116903,16,renal,O
116903,16,failure,O
116903,16,.,O
116903,16,3,O
116903,16,.,O
116903,16,Methicillin-resistant,B-Reason
116903,16,coagulase-negative,I-Reason
116903,16,staphylococcal,I-Reason
116903,16,bacteremia,I-Reason
116903,16,;,O
116903,16,on,O
116903,16,vancomycin,B-Drug
116903,16,.,O
116903,16,MEDICATIONS,O
116903,16,ON,O
116903,16,DISCHARGE,O
116903,16,:,O
116903,16,1,O
116903,16,.,O
116903,17,Miconazole,B-Drug
116903,17,nitrate,I-Drug
116903,17,powder,O
116903,17,applied,O
116903,17,three,O
116903,17,times,O
116903,17,per,O
116903,17,day,O
116903,17,as,O
116903,17,needed,O
116903,17,to,O
116903,17,groin,B-Reason
116903,17,rash,I-Reason
116903,17,.,O
116903,17,2,O
116903,17,.,O
116903,17,Protonix,B-Drug
116903,17,40,O
116903,17,mg,O
116903,17,q.12h,O
116903,17,.,O
116903,17,3,O
116903,17,.,O
116903,17,Lactulose,B-Drug
116903,17,30,O
116903,17,mL,O
116903,17,by,O
116903,17,mouth,O
116903,17,three,O
116903,17,times,O
116903,17,per,O
116903,17,day,O
116903,17,(,O
116903,17,titrated,O
116903,17,to,O
116903,17,four,O
116903,17,to,O
116903,17,five,O
116903,17,bowel,O
116903,17,movements,O
116903,17,per,O
116903,17,day,O
116903,17,),O
116903,17,.,O
116903,17,4,O
116903,17,.,O
116903,17,Vancomycin,B-Drug
116903,17,1,O
116903,17,gram,O
116903,17,intravenously,O
116903,17,q.12h,O
116903,17,.,O
116903,17,(,O
116903,17,for,O
116903,17,a,O
116903,17,total,O
116903,17,of,O
116903,17,six,O
116903,17,weeks,O
116903,17,),O
116903,17,;,O
116903,17,his,O
116903,17,vancomycin,B-Drug
116903,17,dose,O
116903,17,will,O
116903,17,be,O
116903,17,changed,O
116903,17,per,O
116903,17,trough,O
116903,17,levels,O
116903,17,and,O
116903,17,his,O
116903,17,renal,O
116903,17,function,O
116903,17,.,O
116903,17,DISCHARGE,O
116903,17,INSTRUCTIONS/FOLLOWUP,O
116903,17,:,O
116903,17,The,O
116903,17,patient,O
116903,17,was,O
116903,17,to,O
116903,17,follow,O
116903,17,up,O
116903,17,in,O
116903,17,the,O
116903,17,Liver,O
116903,17,Clinic,O
116903,17,in,O
116903,17,two,O
116903,17,days,O
116903,17,from,O
116903,17,discharge,O
116903,17,.,O
116903,18,[,O
116903,18,*,O
116903,18,*,O
116903,18,First,O
116903,18,Name11,O
116903,18,(,O
116903,18,Name,O
116903,18,Pattern1,O
116903,18,),O
116903,18,*,O
116903,18,*,O
116903,18,],O
116903,18,[,O
116903,18,*,O
116903,18,*,O
116903,18,Last,O
116903,18,Name,O
116903,18,(,O
116903,18,NamePattern1,O
116903,18,),O
116903,18,8507,O
116903,18,*,O
116903,18,*,O
116903,18,],O
116903,18,",",O
116903,18,M.D,O
116903,18,.,O
116903,18,[,O
116903,18,*,O
116903,18,*,O
116903,18,MD,O
116903,18,Number,O
116903,18,(,O
116903,18,2,O
116903,18,),O
116903,18,22654,O
116903,18,*,O
116903,18,*,O
116903,18,],O
116903,18,Dictated,O
116903,18,By,O
116903,18,:,O
116903,18,[,O
116903,18,*,O
116903,18,*,O
116903,18,Last,O
116903,18,Name,O
116903,18,(,O
116903,18,NamePattern1,O
116903,18,),O
116903,18,11207,O
116903,18,*,O
116903,18,*,O
116903,18,],O
116903,18,MEDQUIST36,O
116903,18,D,O
116903,18,:,O
116903,18,[,O
116903,18,*,O
116903,18,*,O
116903,18,2138-4-7,O
116903,18,*,O
116903,18,*,O
116903,18,],O
116903,18,15:21,O
116903,18,T,O
116903,18,:,O
116903,18,[,O
116903,18,*,O
116903,18,*,O
116903,18,2138-4-9,O
116903,18,*,O
116903,18,*,O
116903,18,],O
116903,18,07:33,O
116903,18,JOB,O
116903,18,#,O
116903,18,:,O
116903,18,[,O
116903,18,*,O
116903,18,*,O
116903,18,Job,O
116903,18,Number,O
116903,18,25451,O
116903,18,*,O
116903,18,*,O
116903,18,],O
